MedTrace Logo

Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis

NCT02266121 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-05-09

No results posted yet for this study

Summary

Noninvasive brain stimulations (NIBS) will be used in MS patients with cognitive impairments to enhance their cognitive aptitudes.

Conditions

  • Relapsing Remitting Multiple Sclerosis
  • Secondary-progressive Multiple Sclerosis
  • Cognitive Deficits
  • Motor Deficits

Interventions

DEVICE

tDCS

Device: transcranial direct current stimulation tDCS tdcs (ELDITH, Neuroconn, Ilmenau, Germany)

Sponsors & Collaborators

  • Université Catholique de Louvain

    collaborator OTHER

  • Teva Pharmaceuticals USA

    collaborator INDUSTRY

  • University Hospital of Mont-Godinne

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2023-05-08
Completion
2023-05-08

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02266121 on ClinicalTrials.gov